Atlas Trials

A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Clinical trial NCT06193434 · COMPLETED

Trial details

NCT number
NCT06193434
Sponsor
Innovent Biologics (Suzhou) Co. Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy ParticipantsAtopic Dermatitis Patients
Start date
2024-01-05
Primary completion
2025-08-20
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.